Clinical Associate Professor
MD, MHSC, FRCPC
School of Population and Public Health, University of British Columbia
2206 East Mall
Vancouver, BC V6T 1Z3
phone: 6048227646

Dr. Marcus Lem is the Director of the Public Health and Preventive Medicine Residency Program at the UBC and Senior Medical Advisor in Public Health Policy for Addiction and Overdose Prevention and Treatment at the BC Centre for Disease Control. Dr. Lem attended McMaster University Medical School and completed his MHSc in Public Health and Epidemiology and residency in Community Medicine at UBC. He was trained in aerospace and diving medicine at the Defence and Civil Institute for Environmental Medicine, and worked as a federal field epidemiologist in the Office of Public Health Security and the TB Prevention and Control Division of Health Canada. He was on the joint Health Canada – Centers for Disease Control and Prevention team investigating SARS in Toronto in 2003, and served as a short-term consultant with UNICEF. From 2004 to 2007, Dr. Lem was the national Communicable Disease Control Specialist and TB Consultant for the First Nations and Inuit Health Branch (FNIHB), and represented FNIHB on the Canadian TB Committee and the National Advisory Committee on Immunization. Subsequently, he held senior medical and executive positions with the Public Health Agency of Canada and Health Canada and was the Medical Health Officer for the Fraser Valley. Dr. Lem’s clinical preventive medicine practice focusses on non-pharmacologic management of chronic pain syndromes. Dr. Lem is a Fellow of the Royal College of Physicians of Canada and a Clinical Associate Professor at the School of Population and Public Health at UBC.

Unit Affiliations
Chair, Health Officers Council of British Columbia
Courses
SPPH 525DL Issues and Concepts in Public Health
SPPH 570/710: Current Issues in Public Health Practice
UBC Vancouver Summer Program – Medicine Package G: Introduction to Population and Public Health Practice

Response of Aboriginal infants to pertussis vaccine components: results of a controlled comparison study. Scheifele D, Halperin S, Lajeunesse C, Dawar M, McCormick R, Lem M. Int J Circumpolar Health 2013, 72:20930.

Gardy JL, Johnston JC, Ho Sui SJ, Cook VJ, Shah L, Brodkin E, Rempel S, Moore R, Zhao Y, Holt R, Varhol R, Birol I, Lem M, Sharma MK, Elwood K, Jones SMJ, Brinkman FSL, Brunham RC, Tang P. Whole genome sequencing and social network analysis of a tuberculosis outbreak. 2011. NEJM. 364:730-9.

Lem, M. Epidemiologic considerations in network modeling of theoretical disease events. In Visualising Network Information. Meeting Proceedings RTO-MP-IST-063, Paper 11. Neuilly-sur-Seine, France: RTO. 2006; (11-1 – 11-6).
Lem M, Moore D, Marion S, Bonner S, Chan K, O’Connell J, Montaner JS, Hogg R. Back to work: correlates of employment among persons receiving highly active antiretroviral therapy. AIDS Care. 2005 Aug;17(6):740-6.

Ofner M, Lem M, Sarwal S, Vearncombe M, Simor A, SARS Investigative Team, CDC,
Cluster of Severe Acute Respiratory Syndrome Cases Among Protected Health Care Workers – Toronto, April 2003. Morbidity and Mortality Weekly Report. Vol. 52 / No. 19 / May 16, 2003.

Dr. Lem’s current work focuses on the development of policies and guidelines to address the current opioid crisis, including overdose prevention and supervised consumption services, opioid medication policy and occupational health and safety for health care workers and first responders.